APO Research
Talk to an analyst

APO RESEARCH · REPORT

Muxiang Betel Nut Pills

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Muxiang Betel Nut Pills Industry Growth and Trends Forecast to 2032

28 December 2025116 pages

Choose your research edition.

Industry ResearchMuxiang Betel Nut Pills Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Muxiang Betel Nut Pills Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Muxiang Betel Nut Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Muxiang Betel Nut Pills Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Muxiang Betel Nut Pills Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Muxiang Betel Nut Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Muxiang Betel Nut Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Muxiang Betel Nut Pills is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Muxiang Betel Nut Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Muxiang Betel Nut Pills include Wuhan Jun'an Pharmaceutical Co., Ltd., Taiyuan Daningtang Pharmaceutical Co., Ltd., Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd., Shanghai Baolong Anqing Pharmaceutical Co., Ltd., Shanxi Wanglong Pharmaceutical Group Co., Ltd., Shandong Guangyutang Chinese Medicine Co., Ltd., Inner Mongolia Datang Pharmaceutical Co., Ltd., Minsheng Pharmaceutical Group Co., Ltd. and Langzhi Group Shuangren Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Muxiang Betel Nut Pills market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Muxiang Betel Nut Pills market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Muxiang Betel Nut Pills market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Muxiang Betel Nut Pills.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Muxiang Betel Nut Pills market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Muxiang Betel Nut Pills Market by Company

Wuhan Jun'an Pharmaceutical Co., Ltd.

Taiyuan Daningtang Pharmaceutical Co., Ltd.

Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd.

Shanghai Baolong Anqing Pharmaceutical Co., Ltd.

Shanxi Wanglong Pharmaceutical Group Co., Ltd.

Shandong Guangyutang Chinese Medicine Co., Ltd.

Inner Mongolia Datang Pharmaceutical Co., Ltd.

Minsheng Pharmaceutical Group Co., Ltd.

Langzhi Group Shuangren Pharmaceutical Co., Ltd.

Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd.

Heilongjiang Shenge Pharmaceutical Co., Ltd.

Henan Xinxin Pharmaceutical Co., Ltd.

Henan Runhong Herbal Pharmaceutical Co., Ltd.

Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.

Guizhou Dechangxiang Pharmaceutical Co., Ltd.

Guangshengyuan Traditional Chinese Medicine Co., Ltd.

Chengde Tianyuan Pharmaceutical Co., Ltd.

Muxiang Betel Nut Pills Segment by Type

10 Bags

12 Bags

Other

Muxiang Betel Nut Pills Segment by Application

Hospital

Clinic

Other

Muxiang Betel Nut Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Muxiang Betel Nut Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Muxiang Betel Nut Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Muxiang Betel Nut Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Muxiang Betel Nut Pills manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Muxiang Betel Nut Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10 Bags Table 2. Major Company of 12 Bags Table 3. Major Company of Other Table 4. Global Muxiang Betel Nut Pills Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 6. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Type (2021-2026) Table 7. Global Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 8. Global Muxiang Betel Nut Pills Sales Market Share in Value by Type (2021-2026) Table 9. Global Muxiang Betel Nut Pills Price by Type (2021-2026) & (US$/Unit) Table 10. Global Muxiang Betel Nut Pills Sales by Type (2027-2032) & (K Units) Table 11. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Type (2027-2032) Table 12. Global Muxiang Betel Nut Pills Sales by Type (2027-2032) & (US$ Million) Table 13. Global Muxiang Betel Nut Pills Sales Market Share in Value by Type (2027-2032) Table 14. Global Muxiang Betel Nut Pills Price by Type (2027-2032) & (US$/Unit) Table 15. North America Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 16. North America Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 18. Europe Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 22. Latin America Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Muxiang Betel Nut Pills Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Muxiang Betel Nut Pills Sales by Type (2021-2026) & (US$ Million) Table 25. Muxiang Betel Nut Pills Industry Trends Table 26. Muxiang Betel Nut Pills Industry Drivers Table 27. Muxiang Betel Nut Pills Industry Opportunities and Challenges Table 28. Muxiang Betel Nut Pills Industry Restraints Table 29. Global Muxiang Betel Nut Pills Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Muxiang Betel Nut Pills Revenue Market Share by Company (2021-2026) Table 31. Global Muxiang Betel Nut Pills Sales by Company (2021-2026) & (K Units) Table 32. Global Muxiang Betel Nut Pills Sales Share by Company (2021-2026) Table 33. Global Muxiang Betel Nut Pills Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Muxiang Betel Nut Pills Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Muxiang Betel Nut Pills Major Company Production Sites and Headquarters Table 36. Global Muxiang Betel Nut Pills Company, Product Type & Application Table 37. Global Muxiang Betel Nut Pills Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Muxiang Betel Nut Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Muxiang Betel Nut Pills Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Muxiang Betel Nut Pills Sales by Region (2021-2026) & (K Units) Table 42. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Region (2021-2026) Table 43. Global Muxiang Betel Nut Pills Sales by Region (2021-2026) & (US$ Million) Table 44. Global Muxiang Betel Nut Pills Sales Market Share in Value by Region (2021-2026) Table 45. Global Muxiang Betel Nut Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Muxiang Betel Nut Pills Sales by Region (2027-2032) & (K Units) Table 47. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Region (2027-2032) Table 48. Global Muxiang Betel Nut Pills Sales by Region (2027-2032) & (US$ Million) Table 49. Global Muxiang Betel Nut Pills Sales Market Share in Value by Region (2027-2032) Table 50. Global Muxiang Betel Nut Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Muxiang Betel Nut Pills Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 53. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Application (2021-2026) Table 54. Global Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 55. Global Muxiang Betel Nut Pills Sales Market Share in Value by Application (2021-2026) Table 56. Global Muxiang Betel Nut Pills Price by Application (2021-2026) & (US$/Unit) Table 57. Global Muxiang Betel Nut Pills Sales by Application (2027-2032) & (K Units) Table 58. Global Muxiang Betel Nut Pills Sales Market Share in Volume by Application (2027-2032) Table 59. Global Muxiang Betel Nut Pills Sales by Application (2027-2032) & (US$ Million) Table 60. Global Muxiang Betel Nut Pills Sales Market Share in Value by Application (2027-2032) Table 61. Global Muxiang Betel Nut Pills Price by Application (2027-2032) & (US$/Unit) Table 62. North America Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 63. North America Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 65. Europe Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 69. Latin America Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Muxiang Betel Nut Pills Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Muxiang Betel Nut Pills Sales by Application (2021-2026) & (US$ Million) Table 72. Wuhan Jun'an Pharmaceutical Co., Ltd. Company Information Table 73. Wuhan Jun'an Pharmaceutical Co., Ltd. Business Overview Table 74. Wuhan Jun'an Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Wuhan Jun'an Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 76. Wuhan Jun'an Pharmaceutical Co., Ltd. Recent Development Table 77. Taiyuan Daningtang Pharmaceutical Co., Ltd. Company Information Table 78. Taiyuan Daningtang Pharmaceutical Co., Ltd. Business Overview Table 79. Taiyuan Daningtang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Taiyuan Daningtang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 81. Taiyuan Daningtang Pharmaceutical Co., Ltd. Recent Development Table 82. Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Company Information Table 83. Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Business Overview Table 84. Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 86. Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Recent Development Table 87. Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Company Information Table 88. Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Business Overview Table 89. Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 91. Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Recent Development Table 92. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Company Information Table 93. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Business Overview Table 94. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 96. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Recent Development Table 97. Shandong Guangyutang Chinese Medicine Co., Ltd. Company Information Table 98. Shandong Guangyutang Chinese Medicine Co., Ltd. Business Overview Table 99. Shandong Guangyutang Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shandong Guangyutang Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 101. Shandong Guangyutang Chinese Medicine Co., Ltd. Recent Development Table 102. Inner Mongolia Datang Pharmaceutical Co., Ltd. Company Information Table 103. Inner Mongolia Datang Pharmaceutical Co., Ltd. Business Overview Table 104. Inner Mongolia Datang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Inner Mongolia Datang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 106. Inner Mongolia Datang Pharmaceutical Co., Ltd. Recent Development Table 107. Minsheng Pharmaceutical Group Co., Ltd. Company Information Table 108. Minsheng Pharmaceutical Group Co., Ltd. Business Overview Table 109. Minsheng Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Minsheng Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 111. Minsheng Pharmaceutical Group Co., Ltd. Recent Development Table 112. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Company Information Table 113. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Business Overview Table 114. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 116. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Recent Development Table 117. Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Company Information Table 118. Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Business Overview Table 119. Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 121. Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Recent Development Table 122. Heilongjiang Shenge Pharmaceutical Co., Ltd. Company Information Table 123. Heilongjiang Shenge Pharmaceutical Co., Ltd. Business Overview Table 124. Heilongjiang Shenge Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Heilongjiang Shenge Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 126. Heilongjiang Shenge Pharmaceutical Co., Ltd. Recent Development Table 127. Henan Xinxin Pharmaceutical Co., Ltd. Company Information Table 128. Henan Xinxin Pharmaceutical Co., Ltd. Business Overview Table 129. Henan Xinxin Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Henan Xinxin Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 131. Henan Xinxin Pharmaceutical Co., Ltd. Recent Development Table 132. Henan Runhong Herbal Pharmaceutical Co., Ltd. Company Information Table 133. Henan Runhong Herbal Pharmaceutical Co., Ltd. Business Overview Table 134. Henan Runhong Herbal Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Henan Runhong Herbal Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 136. Henan Runhong Herbal Pharmaceutical Co., Ltd. Recent Development Table 137. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information Table 138. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 139. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 141. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 142. Guizhou Dechangxiang Pharmaceutical Co., Ltd. Company Information Table 143. Guizhou Dechangxiang Pharmaceutical Co., Ltd. Business Overview Table 144. Guizhou Dechangxiang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Guizhou Dechangxiang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 146. Guizhou Dechangxiang Pharmaceutical Co., Ltd. Recent Development Table 147. Guangshengyuan Traditional Chinese Medicine Co., Ltd. Company Information Table 148. Guangshengyuan Traditional Chinese Medicine Co., Ltd. Business Overview Table 149. Guangshengyuan Traditional Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Guangshengyuan Traditional Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 151. Guangshengyuan Traditional Chinese Medicine Co., Ltd. Recent Development Table 152. Chengde Tianyuan Pharmaceutical Co., Ltd. Company Information Table 153. Chengde Tianyuan Pharmaceutical Co., Ltd. Business Overview Table 154. Chengde Tianyuan Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Chengde Tianyuan Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio Table 156. Chengde Tianyuan Pharmaceutical Co., Ltd. Recent Development Table 157. North America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Muxiang Betel Nut Pills Sales by Country (2021-2026) & (K Units) Table 159. North America Muxiang Betel Nut Pills Sales Market Share by Country (2021-2026) Table 160. North America Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Muxiang Betel Nut Pills Sales Market Share Forecast by Country (2027-2032) Table 162. North America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Muxiang Betel Nut Pills Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Muxiang Betel Nut Pills Market Share by Country (2021-2026) Table 165. North America Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Muxiang Betel Nut Pills Market Share Forecast by Country (2027-2032) Table 167. Europe Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Muxiang Betel Nut Pills Sales by Country (2021-2026) & (K Units) Table 169. Europe Muxiang Betel Nut Pills Sales Market Share by Country (2021-2026) Table 170. Europe Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Muxiang Betel Nut Pills Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Muxiang Betel Nut Pills Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Muxiang Betel Nut Pills Market Share by Country (2021-2026) Table 175. Europe Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Muxiang Betel Nut Pills Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Muxiang Betel Nut Pills Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Muxiang Betel Nut Pills Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Muxiang Betel Nut Pills Market Share by Country (2021-2026) Table 185. Asia-Pacific Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Muxiang Betel Nut Pills Market Share Forecast by Country (2027-2032) Table 187. Latin America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Muxiang Betel Nut Pills Sales by Country (2021-2026) & (K Units) Table 189. Latin America Muxiang Betel Nut Pills Sales Market Share by Country (2021-2026) Table 190. Latin America Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Muxiang Betel Nut Pills Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Muxiang Betel Nut Pills Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Muxiang Betel Nut Pills Market Share by Country (2021-2026) Table 195. Latin America Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Muxiang Betel Nut Pills Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Muxiang Betel Nut Pills Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Muxiang Betel Nut Pills Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Muxiang Betel Nut Pills Market Share by Country (2021-2026) Table 205. Middle East and Africa Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Muxiang Betel Nut Pills Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Muxiang Betel Nut Pills Distributors List Table 210. Muxiang Betel Nut Pills Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Muxiang Betel Nut Pills Image Figure 2. Global Muxiang Betel Nut Pills Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Muxiang Betel Nut Pills Market Size (2021-2032) & (US$ Million) Figure 4. Global Muxiang Betel Nut Pills Sales (2021-2032) & (K Units) Figure 5. 10 Bags Image Figure 6. Global 10 Bags Sales YoY Growth (2021-2032) & (K Units) Figure 7. 12 Bags Image Figure 8. Global 12 Bags Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Muxiang Betel Nut Pills Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Muxiang Betel Nut Pills Market Share by Type 2025 VS 2032 Figure 13. North America Muxiang Betel Nut Pills Sales Market Share in Volume by Type in 2025 Figure 14. North America Muxiang Betel Nut Pills Sales Market Share in Value by Type in 2025 Figure 15. Europe Muxiang Betel Nut Pills Sales Market Share in Volume by Type in 2025 Figure 16. Europe Muxiang Betel Nut Pills Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share in Value by Type in 2025 Figure 19. Latin America Muxiang Betel Nut Pills Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Muxiang Betel Nut Pills Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Muxiang Betel Nut Pills Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Muxiang Betel Nut Pills Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Muxiang Betel Nut Pills Market Share by Application 2025 VS 2032 Figure 33. North America Muxiang Betel Nut Pills Sales Market Share in Volume by Application in 2025 Figure 34. North America Muxiang Betel Nut Pills Sales Market Share in Value by Application in 2025 Figure 35. Europe Muxiang Betel Nut Pills Sales Market Share in Volume by Application in 2025 Figure 36. Europe Muxiang Betel Nut Pills Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Muxiang Betel Nut Pills Sales Market Share in Value by Application in 2025 Figure 39. Latin America Muxiang Betel Nut Pills Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Muxiang Betel Nut Pills Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Muxiang Betel Nut Pills Sales Market Share in Value by Application in 2025 Figure 43. North America Muxiang Betel Nut Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Muxiang Betel Nut Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Muxiang Betel Nut Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Muxiang Betel Nut Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Muxiang Betel Nut Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Muxiang Betel Nut Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Muxiang Betel Nut Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Muxiang Betel Nut Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Muxiang Betel Nut Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Muxiang Betel Nut Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Muxiang Betel Nut Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Muxiang Betel Nut Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Muxiang Betel Nut Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Muxiang Betel Nut Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Muxiang Betel Nut Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Muxiang Betel Nut Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Muxiang Betel Nut Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Muxiang Betel Nut Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Muxiang Betel Nut Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Muxiang Betel Nut Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Muxiang Betel Nut Pills Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Muxiang Betel Nut Pills Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10 Bags
  • 12 Bags
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Wuhan Jun'an Pharmaceutical Co., Ltd.
  • Taiyuan Daningtang Pharmaceutical Co., Ltd.
  • Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd.
  • Shanghai Baolong Anqing Pharmaceutical Co., Ltd.
  • Shanxi Wanglong Pharmaceutical Group Co., Ltd.
  • Shandong Guangyutang Chinese Medicine Co., Ltd.
  • Inner Mongolia Datang Pharmaceutical Co., Ltd.
  • Minsheng Pharmaceutical Group Co., Ltd.
  • Langzhi Group Shuangren Pharmaceutical Co., Ltd.
  • Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd.
  • Heilongjiang Shenge Pharmaceutical Co., Ltd.
  • Henan Xinxin Pharmaceutical Co., Ltd.
  • Henan Runhong Herbal Pharmaceutical Co., Ltd.
  • Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.
  • Guizhou Dechangxiang Pharmaceutical Co., Ltd.
  • Guangshengyuan Traditional Chinese Medicine Co., Ltd.
  • Chengde Tianyuan Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Muxiang Betel Nut Pills Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Muxiang Betel Nut Pills Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Muxiang Betel Nut Pills Market by Type
  6. 1.3.1 10 Bags
  7. 1.3.2 12 Bags
  8. 1.3.3 Other
  9. 1.4 Global Muxiang Betel Nut Pills Market Size by Type
  10. 1.4.1 Global Muxiang Betel Nut Pills Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Muxiang Betel Nut Pills Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Muxiang Betel Nut Pills Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Muxiang Betel Nut Pills Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Muxiang Betel Nut Pills Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Muxiang Betel Nut Pills Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Muxiang Betel Nut Pills Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Muxiang Betel Nut Pills Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Muxiang Betel Nut Pills Industry Trends
  2. 2.2 Muxiang Betel Nut Pills Industry Drivers
  3. 2.3 Muxiang Betel Nut Pills Industry Opportunities and Challenges
  4. 2.4 Muxiang Betel Nut Pills Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Muxiang Betel Nut Pills Revenue (2021-2026)
  2. 3.2 Global Top Players by Muxiang Betel Nut Pills Sales (2021-2026)
  3. 3.3 Global Top Players by Muxiang Betel Nut Pills Price (2021-2026)
  4. 3.4 Global Muxiang Betel Nut Pills Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Muxiang Betel Nut Pills Major Company Production Sites & Headquarters
  6. 3.6 Global Muxiang Betel Nut Pills Company, Product Type & Application
  7. 3.7 Global Muxiang Betel Nut Pills Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Muxiang Betel Nut Pills Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Muxiang Betel Nut Pills Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Muxiang Betel Nut Pills Tier 1, Tier 2, and Tier 3
4 Muxiang Betel Nut Pills Regional Status and Outlook
  1. 4.1 Global Muxiang Betel Nut Pills Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Muxiang Betel Nut Pills Historic Market Size by Region
  3. 4.2.1 Global Muxiang Betel Nut Pills Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Muxiang Betel Nut Pills Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Muxiang Betel Nut Pills Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Muxiang Betel Nut Pills Forecasted Market Size by Region
  7. 4.3.1 Global Muxiang Betel Nut Pills Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Muxiang Betel Nut Pills Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Muxiang Betel Nut Pills Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Muxiang Betel Nut Pills by Application
  1. 5.1 Muxiang Betel Nut Pills Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Muxiang Betel Nut Pills Market Size by Application
  6. 5.2.1 Global Muxiang Betel Nut Pills Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Muxiang Betel Nut Pills Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Muxiang Betel Nut Pills Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Muxiang Betel Nut Pills Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Muxiang Betel Nut Pills Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Muxiang Betel Nut Pills Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Muxiang Betel Nut Pills Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Muxiang Betel Nut Pills Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Jun'an Pharmaceutical Co., Ltd.
  2. 6.1.1 Wuhan Jun'an Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Wuhan Jun'an Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Wuhan Jun'an Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Jun'an Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  6. 6.1.5 Wuhan Jun'an Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Taiyuan Daningtang Pharmaceutical Co., Ltd.
  8. 6.2.1 Taiyuan Daningtang Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Taiyuan Daningtang Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Taiyuan Daningtang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taiyuan Daningtang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  12. 6.2.5 Taiyuan Daningtang Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd.
  14. 6.3.1 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  18. 6.3.5 Shanghai Leiyunshang Fengbang Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shanghai Baolong Anqing Pharmaceutical Co., Ltd.
  20. 6.4.1 Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  24. 6.4.5 Shanghai Baolong Anqing Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shanxi Wanglong Pharmaceutical Group Co., Ltd.
  26. 6.5.1 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Company Information
  27. 6.5.2 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Business Overview
  28. 6.5.3 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  30. 6.5.5 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Recent Developments
  31. 6.6 Shandong Guangyutang Chinese Medicine Co., Ltd.
  32. 6.6.1 Shandong Guangyutang Chinese Medicine Co., Ltd. Company Information
  33. 6.6.2 Shandong Guangyutang Chinese Medicine Co., Ltd. Business Overview
  34. 6.6.3 Shandong Guangyutang Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Guangyutang Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  36. 6.6.5 Shandong Guangyutang Chinese Medicine Co., Ltd. Recent Developments
  37. 6.7 Inner Mongolia Datang Pharmaceutical Co., Ltd.
  38. 6.7.1 Inner Mongolia Datang Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Inner Mongolia Datang Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Inner Mongolia Datang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Inner Mongolia Datang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  42. 6.7.5 Inner Mongolia Datang Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Minsheng Pharmaceutical Group Co., Ltd.
  44. 6.8.1 Minsheng Pharmaceutical Group Co., Ltd. Company Information
  45. 6.8.2 Minsheng Pharmaceutical Group Co., Ltd. Business Overview
  46. 6.8.3 Minsheng Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Minsheng Pharmaceutical Group Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  48. 6.8.5 Minsheng Pharmaceutical Group Co., Ltd. Recent Developments
  49. 6.9 Langzhi Group Shuangren Pharmaceutical Co., Ltd.
  50. 6.9.1 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  54. 6.9.5 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd.
  56. 6.10.1 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  60. 6.10.5 Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Heilongjiang Shenge Pharmaceutical Co., Ltd.
  62. 6.11.1 Heilongjiang Shenge Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Heilongjiang Shenge Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Heilongjiang Shenge Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Heilongjiang Shenge Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  66. 6.11.5 Heilongjiang Shenge Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Henan Xinxin Pharmaceutical Co., Ltd.
  68. 6.12.1 Henan Xinxin Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Henan Xinxin Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Henan Xinxin Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Henan Xinxin Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  72. 6.12.5 Henan Xinxin Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Henan Runhong Herbal Pharmaceutical Co., Ltd.
  74. 6.13.1 Henan Runhong Herbal Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Henan Runhong Herbal Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Henan Runhong Herbal Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Henan Runhong Herbal Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  78. 6.13.5 Henan Runhong Herbal Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.
  80. 6.14.1 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  84. 6.14.5 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Guizhou Dechangxiang Pharmaceutical Co., Ltd.
  86. 6.15.1 Guizhou Dechangxiang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Guizhou Dechangxiang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Guizhou Dechangxiang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guizhou Dechangxiang Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  90. 6.15.5 Guizhou Dechangxiang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Guangshengyuan Traditional Chinese Medicine Co., Ltd.
  92. 6.16.1 Guangshengyuan Traditional Chinese Medicine Co., Ltd. Company Information
  93. 6.16.2 Guangshengyuan Traditional Chinese Medicine Co., Ltd. Business Overview
  94. 6.16.3 Guangshengyuan Traditional Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangshengyuan Traditional Chinese Medicine Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  96. 6.16.5 Guangshengyuan Traditional Chinese Medicine Co., Ltd. Recent Developments
  97. 6.17 Chengde Tianyuan Pharmaceutical Co., Ltd.
  98. 6.17.1 Chengde Tianyuan Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Chengde Tianyuan Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Chengde Tianyuan Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chengde Tianyuan Pharmaceutical Co., Ltd. Muxiang Betel Nut Pills Product Portfolio
  102. 6.17.5 Chengde Tianyuan Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Muxiang Betel Nut Pills Sales by Country
  2. 7.1.1 North America Muxiang Betel Nut Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Muxiang Betel Nut Pills Sales by Country (2021-2026)
  4. 7.1.3 North America Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032)
  5. 7.2 North America Muxiang Betel Nut Pills Market Size by Country
  6. 7.2.1 North America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Muxiang Betel Nut Pills Market Size by Country (2021-2026)
  8. 7.2.3 North America Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Muxiang Betel Nut Pills Sales by Country
  2. 8.1.1 Europe Muxiang Betel Nut Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Muxiang Betel Nut Pills Sales by Country (2021-2026)
  4. 8.1.3 Europe Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Muxiang Betel Nut Pills Market Size by Country
  6. 8.2.1 Europe Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Muxiang Betel Nut Pills Market Size by Country (2021-2026)
  8. 8.2.3 Europe Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Muxiang Betel Nut Pills Sales by Country
  2. 9.1.1 Asia-Pacific Muxiang Betel Nut Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Muxiang Betel Nut Pills Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Muxiang Betel Nut Pills Market Size by Country
  6. 9.2.1 Asia-Pacific Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Muxiang Betel Nut Pills Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Muxiang Betel Nut Pills Sales by Country
  2. 10.1.1 South America Muxiang Betel Nut Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Muxiang Betel Nut Pills Sales by Country (2021-2026)
  4. 10.1.3 South America Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032)
  5. 10.2 South America Muxiang Betel Nut Pills Market Size by Country
  6. 10.2.1 South America Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Muxiang Betel Nut Pills Market Size by Country (2021-2026)
  8. 10.2.3 South America Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Muxiang Betel Nut Pills Sales by Country
  2. 11.1.1 Middle East and Africa Muxiang Betel Nut Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Muxiang Betel Nut Pills Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Muxiang Betel Nut Pills Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Muxiang Betel Nut Pills Market Size by Country
  6. 11.2.1 Middle East and Africa Muxiang Betel Nut Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Muxiang Betel Nut Pills Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Muxiang Betel Nut Pills Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Muxiang Betel Nut Pills Value Chain Analysis
  2. 12.1.1 Muxiang Betel Nut Pills Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Muxiang Betel Nut Pills Production Mode & Process
  7. 12.2 Muxiang Betel Nut Pills Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Muxiang Betel Nut Pills Distributors
  10. 12.2.3 Muxiang Betel Nut Pills Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst